These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23292829)

  • 1. Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma.
    Lu JW; Lin YM; Chang JG; Yeh KT; Chen RM; Tsai JJ; Su WW; Hu RM
    Med Oncol; 2013 Mar; 30(1):379. PubMed ID: 23292829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
    Chen XQ; He JR; Wang HY
    Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma.
    Kim H; Lee MJ; Kim MR; Chung IP; Kim YM; Lee JY; Jang JJ
    Liver; 2000 Apr; 20(2):173-8. PubMed ID: 10847487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Sugimoto K; Tai Y; Tokuda M
    Int J Cancer; 2001 Jul; 95(4):209-15. PubMed ID: 11400112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlations of expressions of macrophage migration inhibitor factor and cyclin D1 with tumor size and metastasis of hepatocellular carcinoma].
    Xia JT; Li W; Liu YJ; Chen LZ; Wu ZF; Zhang LJ; Wang Q
    Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):918-21. PubMed ID: 18171527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
    Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY
    Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.
    Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
    Clin Transl Oncol; 2014 Jan; 16(1):57-63. PubMed ID: 23632812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
    Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
    World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
    Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer.
    Peurala E; Koivunen P; Haapasaari KM; Bloigu R; Jukkola-Vuorinen A
    Breast Cancer Res; 2013 Jan; 15(1):R5. PubMed ID: 23336272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma.
    Peng SY; Chou SP; Hsu HC
    J Hepatol; 1998 Aug; 29(2):281-9. PubMed ID: 9722210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma.
    Kong J; Zhou X; Liu S; Jin T; Piao Y; Liu C; Lin Z
    Int J Clin Exp Pathol; 2014; 7(6):3018-27. PubMed ID: 25031720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma.
    Matsumoto M; Furihata M; Ishikawa T; Ohtsuki Y; Ogoshi S
    Br J Cancer; 1999 Apr; 80(1-2):256-61. PubMed ID: 10390005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.
    Ding Y; Chen B; Wang S; Zhao L; Chen J; Ding Y; Chen L; Luo R
    Int J Cancer; 2009 Feb; 124(3):653-8. PubMed ID: 18972435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity.
    Takano Y; Takenaka H; Kato Y; Masuda M; Mikami T; Saegusa M; Okayasu I
    J Cancer Res Clin Oncol; 1999; 125(8-9):505-12. PubMed ID: 10480344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.